Oct. 4 at 6:40 AM
MAJI / Exousia AI – Real Assets Behind the Story
For those wondering if
$MAJI has anything real behind it, here are some key facts I’ve been able to verify:
✅ Acquisition of Exousia AI – On Jan 6, 2025 MAJI acquired 100% of Exousia AI, issuing 47M restricted shares to Ludwig Enterprises.
✅ Provisional Patent Filed – On Sept 10, 2025, Exousia Pro filed provisional patent #63/877,517 for a novel extracellular vesicle loading method to improve efficiency and stability of therapeutic delivery.
✅ Orphan Drug Application – FDA requested additional data regarding Exousia AI’s Orphan Drug designation filing for glioblastoma. Study underway at UCF, expected results by mid-year.
✅ Renegotiated License with Progenicyte – Agreement revised from 50% to 30% equity in exchange for worldwide rights to the exosome patent.
✅ Corporate Development – New divisions launched (Exousia Health, Exousia Wholesale, etc.) and FINRA filings in process for subsidiary name changes.
✅ Reg A Offering